Filing Details

Accession Number:
0001209191-23-045087
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-08 19:10:21
Reporting Period:
2023-08-04
Accepted Time:
2023-08-08 19:10:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324015 William Jeffrey Henderson C/O Fibrogen, Inc.
409 Illinois Street
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-04 2,000 $1.91 30,866 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold by the reporting person pursuant to a 10b5-1 trading plan dated March 3, 2023.
  2. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $1.865 to $1.925. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.